Concepedia

A. D. Krikorian

AD

6

Publications

122

Citations

6

H-Index

2013

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

WuXi AppTec (China)

A. D. Krikorian is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug discovery, medicinal chemistry, and medicine.

Top concepts

Publications per year

2013–2020

6

Publications

6

Discovery of 8-Amino-imidazo[1,5-<i>a</i>]pyrazines as Reversible BTK Inhibitors for the Treatment of Rheumatoid Arthritis

Jian Liu, Deodial Guiadeen, A. D. Krikorian et al. · ACS Medicinal Chemistry Letters · 2015 · 38 citations · Full text

, , +23

Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety

Shuwen He, Qingmei Hong, Zhong Lai et al. · ACS Medicinal Chemistry Letters · 2014 · 26 citations · Full text

, , +22

Discovery of novel BTK inhibitors with carboxylic acids

Xiaolei Gao, James Wang, Jian Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2016 · 18 citations · Full text

, , +5

Potent, non-covalent reversible BTK inhibitors with 8-amino-imidazo[1,5-a]pyrazine core featuring 3-position bicyclic ring substitutes

Jian Liu, Deodial Guiadeen, A. D. Krikorian et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 16 citations · Full text

, , +7

Discovery of 3-morpholino-imidazole[1,5-a]pyrazine BTK inhibitors for rheumatoid arthritis

Sobhana Babu Boga, Abdul‐Basit Alhassan, Jian Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2017 · 13 citations · Full text

, , +5

Rows per page

1–5 of 6